Click it and Unblock the Notifications
Shares in Cipla jumped sharply by 7 per cent after the pharma major launched an anti-asthma inhaler in Germany and Sweden. the stock was last trading at Rs 564 on the Bombay Stock Exchange.
The inhaler is a generic version of GlaxoSmithKline Plc's Advair.
Noted broking firm, Emkay Global upgraded the stock to "buy" from "accumulate" with a target of 671 rupees.
Overall addressable opportunity of generic Advair is $800 million in Europe, Emkay said.
Cipla shares were trading up 7.1 percent to 566.75 rupees as of 10:02 a.m.
GoodReturns.in
More From GoodReturns
Crash in Gold Rate in India by Rs 71,400 in Single Day; Will Gold Price Today Fall Below Rs 1.50 Lakh? Outlook
Gold & Silver Rates Today Live: MCX Gold Crashes By Rs 5,645, Silver Falls By Rs 16,540; 24K, 22K, 18K Gold
1:5 Split Soon? Vedanta Ltd To Consider 3rd Interim Dividend On March 23, Share Jumps; Record Date & Buy Call
Sleeper Vande Bharat Express New Routes Identified for Long Distance Travel
Gold & Silver Rates Today Live Updates: Will 24 Carat, 22 Carat, 18 Carat See Bullish Week Ahead?
Mega Gold Price Crash Alert! 24K Sinks Rs 1.36 Lakh/100 Gm In Week; Silver Sees Losses | March 23-27 Outlook
Gold & Silver Rates Today Live: MCX Gold Ends Above Rs 1.40 Lakh, Silver Up 1%; 24K, 22K, 18K Gold On March 24
Gold Rate Crashes Over Rs 1 Lakh in Single Day, Slips to Lowest Since January; Will Gold Price Today Decline?
Gold Price Crash May Fuel Jewellery Demand: Why Kalyan Jewellers Share Price Could Shine Despite 5% Dip
Fatal Crash In Gold Rates In India By Rs 1,03,200/100 Gm; Biggest Single-Day Fall In 24K, 22K, 18K Gold Prices
Gold Rates In India Crash By Rs 29,400 On March 21 After Spot Gold Hits Weakest Week; 24K, 22K, 18K Gold Price
Sign in with Google